Gargling with Gold Nanoparticles Provides a Non-invasive Way to Diagnose Cancer and May Provide Pathologists with a Useful New Clinical Laboratory Test

Researchers at Israel’s Bar-Ilan University attract attention with their unique assay that detects cancers of the tongue and the larynx Researchers in Israel developed a non-invasive oral test for cancers of the tongue and larynx that uses gold nanoparticles and antibodies to “paint” cancer cells. An imaging tool then allows physicians to identify any tumor cells that may be present. This demonstration of how the combination of gold nanoparticles and antibodies can detect cancer may form the...

IBM Invests $100 Million in Healthcare Informatics, but That is Not Unusual for IBM

Company will develop solutions for new reimbursement models, evidence-based care, and supporting health service delivery needs Earlier this fall, IBM Corporation (NYSE: IBM) announced plans to invest $100 million specifically to advance IBM capabilities in three key areas of healthcare informatics. That seemed like a big deal that might affect clinical pathology, since IBM is one of the information technology (IT) giants in the United States. However, Dark Daily editors made a surprising...

New Technology Captures Tumor Cells from the Bloodstream

Nano-technology Breakthrough May Prevent Cancers from Metastasizing With the goal of removing tumor cells from the bloodstream, a biomedical engineering team at the University of Arkansas for Medical Sciences (UAMS) in Little Rock has discovered a non-invasive way to identify cancer and to capture tumor cells in the bloodstream. This landmark discovery, could dramatically improve early cancer diagnosis and prevent deadly metastasis. It could also provide a framework for a new type of...
;